GeoVax Labs, Inc.
| OTC Markets: GOVX
GeoVax Labs, Inc. is a biotechnology company developing vaccines that prevent and fight Human Immunodeficiency Virus infections, which result in acquired Immunodeficiency Syndrome. Its vaccine candidates completed preclinical efficacy testing in non-human primates and a Phase I clinical study in humans. The companies ongoing research and development programs are focused on the clinical development of its DNA and MVA vaccines for the prevention and or treatment of HIV/AIDS. GeoVax Labs was founded on September 28, 2006 and is headquartered in Smyrna, GA.